Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.

Dos Santos Guimarães I, Ladislau-Magescky T, Tessarollo NG, Dos Santos DZ, Gimba ERP, Sternberg C, Silva IV, Rangel LBA.

Pharmacol Rep. 2018 Jun;70(3):409-417. doi: 10.1016/j.pharep.2017.11.007. Epub 2017 Nov 21.

PMID:
29627688
2.

Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines.

Marques DS, Grativol J, Alves da Silva Peres R, da Rocha Matos A, Gimba ERP.

Tumour Biol. 2017 Sep;39(9):1010428317725442. doi: 10.1177/1010428317725442.

PMID:
28936921
3.

Osteopontin and their roles in hematological malignancies: Splice variants on the new avenues.

Bastos ACSF, Blunck CB, Emerenciano M, Gimba ERP.

Cancer Lett. 2017 Nov 1;408:138-143. doi: 10.1016/j.canlet.2017.08.022. Epub 2017 Aug 24. Review.

PMID:
28844708
4.

Lycopene Extracts from Different Tomato-Based Food Products Induce Apoptosis in Cultured Human Primary Prostate Cancer Cells and Regulate TP53, Bax and Bcl-2 Transcript Expression

Soares ND, Machado CL, Trindade BB, Lima IC, Gimba ER, Teodoro AJ, Takiya Ch, Borojevic R.

Asian Pac J Cancer Prev. 2017 Feb 1;18(2):339-345.

5.

Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.

Ferreira LB, Tavares C, Pestana A, Pereira CL, Eloy C, Pinto MT, Castro P, Batista R, Rios E, Sobrinho-Simões M, Gimba ER, Soares P.

Oncotarget. 2016 Aug 9;7(32):52003-52016. doi: 10.18632/oncotarget.10468.

6.

PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells.

Lemos AE, Ferreira LB, Batoreu NM, de Freitas PP, Bonamino MH, Gimba ER.

Tumour Biol. 2016 Aug;37(8):11339-48. doi: 10.1007/s13277-016-5012-3. Epub 2016 Mar 9.

PMID:
26960690
7.

Aberrant levels of Wnt/β-catenin pathway components in a rat model of endometriosis.

de Mattos RM, Pereira PR, Barros EG, da Silva JH, Palmero CY, da Costa NM, Pinto LF, Gimba ER, Hecht F, Ferreira LB, Machado DE, de Oliveira FL, Nasciutti LE.

Histol Histopathol. 2016 Aug;31(8):933-42. doi: 10.14670/HH-11-730. Epub 2016 Feb 8.

PMID:
26853489
8.

Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells.

Nakamura KD, Tilli TM, Wanderley JL, Palumbo A Jr, Mattos RM, Ferreira AC, Klumb CE, Nasciutti LE, Gimba ER.

Tumour Biol. 2016 Feb;37(2):2655-63. doi: 10.1007/s13277-015-4095-6. Epub 2015 Sep 24.

PMID:
26404131
9.
10.
11.

Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations.

Fachel AA, Tahira AC, Vilella-Arias SA, Maracaja-Coutinho V, Gimba ER, Vignal GM, Campos FS, Reis EM, Verjovski-Almeida S.

Mol Cancer. 2013 Nov 15;12(1):140. doi: 10.1186/1476-4598-12-140.

12.

Influence of lycopene on cell viability, cell cycle, and apoptosis of human prostate cancer and benign hyperplastic cells.

Soares Nda C, Teodoro AJ, Oliveira FL, Santos CA, Takiya CM, Junior OS, Bianco M, Junior AP, Nasciutti LE, Ferreira LB, Gimba ER, Borojevic R.

Nutr Cancer. 2013;65(7):1076-85. doi: 10.1080/01635581.2013.812225. Epub 2013 Sep 20.

PMID:
24053141
13.

Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.

Matos AR, Coutinho-Camillo CM, Thuler LC, Fonseca FP, Soares FA, Silva EA, Gimba ER.

Exp Mol Pathol. 2013 Jun;94(3):438-44. doi: 10.1016/j.yexmp.2013.02.002. Epub 2013 Mar 5.

PMID:
23470460
14.

Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways.

Gimba ER, Tilli TM.

Cancer Lett. 2013 Apr 30;331(1):11-7. doi: 10.1016/j.canlet.2012.12.003. Epub 2012 Dec 12. Review.

PMID:
23246372
15.

PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.

Ferreira LB, Palumbo A, de Mello KD, Sternberg C, Caetano MS, de Oliveira FL, Neves AF, Nasciutti LE, Goulart LR, Gimba ER.

BMC Cancer. 2012 Nov 6;12:507. doi: 10.1186/1471-2407-12-507.

16.

Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.

Tilli TM, Mello KD, Ferreira LB, Matos AR, Accioly MT, Faria PA, Bellahcène A, Castronovo V, Gimba ER.

Prostate. 2012 Nov;72(15):1688-99. doi: 10.1002/pros.22523. Epub 2012 Apr 11.

PMID:
22495819
17.

Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells.

Palumbo A Jr, Ferreira LB, Reis de Souza PA, Oliveira FL, Pontes B, Viana NB, Machado DE, Palmero CY, Alves LM, Gimba ER, Nasciutti LE.

Cancer Lett. 2012 Aug 1;321(1):55-64. doi: 10.1016/j.canlet.2012.02.026. Epub 2012 Feb 28.

18.

Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.

Tilli TM, Thuler LC, Matos AR, Coutinho-Camillo CM, Soares FA, da Silva EA, Neves AF, Goulart LR, Gimba ER.

Exp Mol Pathol. 2012 Feb;92(1):13-9. doi: 10.1016/j.yexmp.2011.09.014. Epub 2011 Sep 22.

PMID:
21963599
19.

Osteopontin-c splicing isoform contributes to ovarian cancer progression.

Tilli TM, Franco VF, Robbs BK, Wanderley JL, da Silva FR, de Mello KD, Viola JP, Weber GF, Gimba ER.

Mol Cancer Res. 2011 Mar;9(3):280-93. doi: 10.1158/1541-7786.MCR-10-0463. Epub 2011 Jan 24.

20.

Osteopontin is a tumor autoantigen in prostate cancer patients.

Tilli TM, Silva EA, Matos LC, Faget DV, Dias BF, Vasconcelos JS, Yokosaki Y, Gimba ER.

Oncol Lett. 2011 Jan;2(1):109-114. Epub 2010 Nov 23.

21.

Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma.

Brito GC, Fachel AA, Vettore AL, Vignal GM, Gimba ER, Campos FS, Barcinski MA, Verjovski-Almeida S, Reis EM.

Mol Carcinog. 2008 Oct;47(10):757-67. doi: 10.1002/mc.20433.

PMID:
18348187
22.

Auto-antibodies in prostate cancer: humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3.

Pontes ER, Matos LC, da Silva EA, Xavier LS, Diaz BL, Small IA, Reis EM, Verjovski-Almeida S, Barcinski MA, Gimba ER.

Prostate. 2006 Oct 1;66(14):1463-73.

PMID:
16897729
23.

Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma.

Guerrero IM, Pessoa CH, Olmedo DB, Pontes ER, Matos LC, Tilli TM, Barcinski MA, Gimba ER.

Thyroid. 2006 Jan;16(1):9-15.

PMID:
16487008
24.

Molecular aspects of prostate cancer: implications for future directions.

Gimba ER, Barcinski MA.

Int Braz J Urol. 2003 Sep-Oct;29(5):401-10; discussion 411.

25.

Dolichol phosphate mannose synthase is differentially expressed in male and female worms of Schistosoma mansoni.

Tempone AJ, Furtado DR, Gimba ER, Oliveira FM, Rumjanek FD.

Comp Biochem Physiol B Biochem Mol Biol. 2002 Mar;131(3):465-74.

PMID:
11959028
26.

Lack of DNA methylation in Schistosoma mansoni.

Fantappié MR, Gimba ER, Rumjanek FD.

Exp Parasitol. 2001 Jul;98(3):162-6.

PMID:
11527439

Supplemental Content

Loading ...
Support Center